Detalles de la búsqueda
1.
Trabectedin use in soft-tissue sarcoma patients in a real-world setting: Data from an Italian national drug-access registry.
Int J Cancer
; 152(4): 761-768, 2023 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36196483
2.
Management of chronic myeloid leukaemia patients treated with ponatinib in a real-life setting: A retrospective analysis from the monitoring registries of the Italian Medicines Agency (AIFA).
Br J Haematol
; 198(6): 965-973, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35904979
3.
Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA).
Ann Hematol
; 100(2): 481-485, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33415425
4.
Effectiveness and management of ponatinib as second-line treatment in chronic myeloid leukemia: an analysis from the monitoring registries of the Italian medicines agency (AIFA).
Ann Hematol
; 102(5): 1257-1259, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36914888
5.
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912].
Lancet Reg Health Eur
; 42: 100940, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38813536
6.
Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study.
Lancet Reg Health Eur
; 41: 100912, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38665620
7.
Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries.
J Am Heart Assoc
; 12(21): e026550, 2023 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37850449
8.
Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines Agency.
Blood Cancer J
; 13(1): 99, 2023 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37380630
9.
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study.
Lancet Reg Health Eur
; 31: 100684, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37547273
10.
Mortality in SARS-CoV-2 Hospitalized Patients Treated with Remdesivir: A Nationwide, Registry-Based Study in Italy.
Viruses
; 14(6)2022 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35746668
11.
A nationwide prospective registry of bortezomib-based therapy in light chain (AL) amyloidosis.
Leuk Lymphoma
; 63(1): 205-211, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34448427
12.
Impact of the COVID-19 pandemic on prescription of sacubitril/valsartan in Italy.
Eur J Heart Fail
; 24(5): 855-860, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35303393
13.
Under-prescription of direct oral anticoagulants for treatment of non-valvular atrial fibrillation and venous thromboembolism in the COVID-19 lockdown period.
Eur J Prev Cardiol
; 29(4): e149-e152, 2022 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34151366
Resultados
1 -
13
de 13
1
Próxima >
>>